Single Arm Phase Ib Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Single Arm Phase Ib Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Single Arm Phase Ib Study Today - Breaking & Trending Today

Antengene Presents Results of Phase 1b TOUCH Trial of Selinexor for the Treatment of T and NK-Cell Lymphoma at the 2021 American Society of Hematology (ASH) Annual Meeting

Published: December 14, 2021

/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering,...

Source: prnewswire.com

Related Topics:

United StatesGeorgia World Congress CenterSouth KoreaHuiqiang HuangKevin LynchJay MeiAsia PacificPeter QianKaryopharm Press Release On NovKaryopharm Therapeutics IncAntengene CorporationSun Yat Sen University Affiliated Cancer HospitalDrug AdministrationSelective Inhibitor Of NuclearAntengene Corporation LimitedLymphoma CenterChief Medical OfficerChief Executive OfficerHeavily Pretreated PatientsPeripheralt Cell LymphomaT Cell LymphomaPreliminary ResultsSingle Arm Phase Ib StudyGeorgia World CongressKaryopharm Therapeutics

Antengene Presents Results of Phase 1b TOUCH Trial of Selinexor for the Treatment of T and NK-Cell Lymphoma at the 2021 American Society of Hematology (ASH) Annual Meeting

Published: December 14, 2021

/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering,...

Source: prnewswire.com

Related Topics:

United StatesGeorgia World Congress CenterSouth KoreaHuiqiang HuangKevin LynchJay MeiAsia PacificPeter QianKaryopharm Press Release On NovKaryopharm Therapeutics IncAntengene CorporationSun Yat Sen University Affiliated Cancer HospitalDrug AdministrationSelective Inhibitor Of NuclearAntengene Corporation LimitedLymphoma CenterChief Medical OfficerChief Executive OfficerHeavily Pretreated PatientsPeripheralt Cell LymphomaT Cell LymphomaPreliminary ResultsSingle Arm Phase Ib StudyGeorgia World CongressKaryopharm Therapeutics